Normative scores of the Cambridge Cognitive Examination-Revised in healthy Spanish population

  1. Pereiro Rozas, Arturo X.
  2. Ramos Lema, Sonia
  3. Juncos Rabadán, Onésimo
  4. Facal Mayo, David
  5. Lojo Seoane, Cristina
Journal:
Psicothema

ISSN: 0214-9915

Year of publication: 2015

Volume: 27

Issue: 1

Pages: 32-39

Type: Article

DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Psicothema

Abstract

Background: The Cambridge Cognitive Examination-Revised (CAMCOG) is widely used in clinical, epidemiological and research studies, but normative scores for age and educational level have not yet been established in the Spanish population. Method: The CAMCOG-R was administered to 730 adult members ofthe community, aged between 50-97 years, living throughout the region of Galicia. Initial screening yielded provisional identification of cognitive impairment and depressive symptoms. The final sample consisted of 643 cognitively healthy adults. The following instruments were administered: a questionnaire concerning socio-demographic and clinical data, the Charlson's Comorbidity Index, the Mini-Mental State Examination, the Montreal Cognitive Assessment (MoCA), the Lawton and Brody Index, a short version of the Geriatric Depression Scale, and the CASP-19 quality of life scale. Results: Internal consistency values of the CAMCOG-R were similar to those obtained for the original scale. The convergent validity between MoCA and CAMCOG-R was good, and the divergent validity between CASP-19 and CAMCOG-R was higher than the recommended value. Percentiles and inter-quartile range for age and educational level were calculated. Conclusions: Psychometric indexes showed that the CAMCOG-R is a reliable and valid instrument, which can generally avoid a ceiling effect. The study findings confirm the importance of specifying the normative data by age and educational level.

Bibliographic References

  • Aprahamian, I., Diniz, B.S., Izbicki, R., Radanovic, M., Nunes, P.V., & Forlenza, O.V. (2011). Optimizing the CAMCOG test in the screening for mild cognitive impairment and incipient dementia: Saving time with relevant domains. International Journal of Geriatric Psychiatry, 26, 403-408.
  • Ballard, C.G., Ayre, G., O’Brien, J., Sahgal, A., McKeith, I.G., Ince, P.G., et al. (1999). Simple standardised neuropsychological assessments aid in the differential diagnosis of Dementia with Lewy Bodies from Alzheimer’s Disease and Vascular Dementia. Dementia and Geriatric Cognitive Disorders, 10, 104-108.
  • Bottino, C.M.C., Stope, A.Jr., Scalco, A.Z., Ferreira, R.C.R., Hototian, S.R., & Scalco, M.Z. (2001). Validade e confiabilidade da versão brasileira do CAMDEX. Arquivos de Neuropsiquiatria, 59, S20.
  • Conde-Sala, JL., Garre-Olmo, J., Vilalta-Franch, J., Llinàs-Reglà, J., Turró-Garriga, O., Lozano-Gallego, M., et al. (2012). Predictors of cognitive decline in Alzheimer’s disease and mild cognitive impairment using the CAMCOG: A fi ve-year follow-up. International Psychogeriatrics, 24, 948-958.
  • Counsell, N., Cortina-Borja, M., Lehtonen, A., & Stein, A. (2011). Modelling psychiatric measures using Skew-Normal distributions. European Psychiatry, 26, 112-114.
  • Charlson, M., Pompei, P., Ales, K.L., & McKenzie, C.R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40, 373-383.
  • de-Koning, I., Dippel, D.W., van Kooten, F., & Koudstaal, P.J. (2000). A short screening instrument for poststroke dementia: The R-CAMCOG. Stroke, 31, 1502-1508.
  • De Pedro-Cuesta, J., Virués-Ortega, J., Vega, S., Seijo-Martínez, M., Saz, P., Rodríguez, F., et al. (2009). Prevalence of dementia and major dementia subtypes in Spanish populations: A reanalysis of dementia prevalence surveys, 1990-2008. BioMed Central Neurology, Oct19, 9-55.
  • DG ECFIN-Directorate-General for Economic and Financial Affairs of the European Commission (2012). The 2012 ageing report: Underlying assumptions and projection methodologies. Brussels: European Commission [cited 2014 Apr 2]. Available from: http://ec.europa. eu/economy_finance/publications/european_economy/2012/pdf/ee-2012-2_en.pdf.
  • Farley, J.F., Harley, C.R., & Devine, J.W. (2006). A comparison of comorbidity measurements to predict healthcare expenditures. American Journal of Managed Care, 12, 110-119.
  • Folstein, M.F., Folstein, S.E., & McHugh, P.R. (1975). “Mini-Mental State”: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
  • Fountoulakis, K.N., Tsolaki, M., & Kazis, A. (2001). Investigation of borderline dementia, particularly of Alzheimer’s type, compared with non-demented patients with similar neuropsychological profiles. International Journal of Psychiatry in Clinical Practice, 5, 55-61.
  • Galician Institute of Statistics (2013). Cifras poboacionais de referencia 2013 [Reference population data] [cited 2014 May 14]. Available from: http://www.ige.eu/igebdt/selector.jsp?COD=5230&paxina=001&c=02 01001006.
  • Gallagher, D., Mhaolain, A.N., Coen, R., Walsh, C., Kilroy, D., Belinski, K., et al. (2010). Detecting prodromal Alzheimer’s disease in mild cognitive impairment: Utility of the CAMCOG and other neuropsychological predictors. International Journal of Geriatric Psychiatry, 25, 1280-1287.
  • Heinik, J., Werner, P., Mendel, A., Raikher, B., & Bleich, A. (1999). The Cambridge cognitive examination (CAMCOG): Validation of the Hebrew version in elderly demented patients. International Journal of Geriatric Psychiatry, 14, 1006-1013.
  • Huppert, F.A., Jorm, A.F., Brayne, C., Girling, D., Barkley, C., Beardsall, L., et al. (1996). Psychometric properties of the CAMCOG and its efficacy in the diagnosis of dementia. Aging, Neuropsychology, and Cognition, 3, 201-214.
  • Hyde, M., Wiggins, R.D., Higgs, P., & Blane, D.B. (2003). A measure of quality of life in early old age: The theory, development and properties of a needs satisfaction model (CASP-19). Aging and Mental Health, 7, 86-94.
  • Izal, M., & Montorio, I. (1993). Adaptation of the geriatric depression scale in Spain: A preliminary study. Clinical Gerontologist, 13, 83-91.
  • Lawton, M.P., & Brody, E.M. (1969). Assessment of older people: Selfmaintaining and instrumental activities of daily living. Gerontologist, 3, 179-186.
  • Lévy Mangin, J.P., Manera, J., Sulé, M.A., De Vicente y Oliva, M.A., Iglesias, S., & Rubio, L. (2001). Modelización y programación estructural con AMOS. Madrid: Instituto Superior de Técnicas y Prácticas Bancarias.
  • Llinàs, J., López Pousa, S., & Vilalta, J. (1995). The efficiency of CAMDEX in the diagnosis of dementia and its subtypes. Neurología, 3, 133-138.
  • Lobo, A., Ezquerra, J., Gómez, F., Sala, J.M., & Seva, A. (1979). El “Mini-Examen Cognoscitivo”: un test sencillo, práctico, para detectar alteraciones intelectivas en pacientes médicos. Actas Luso-Españolas de Neurología, Psiquiatría y Ciencias Afines, 3, 189-202.
  • Lobo, A., Saza, P., Marcos, G., Díaz, J.L., De la Cámara, C., Ventura, T., et al. (1999). Revalidación y normalización del Mini-Examen Cognoscitivo (primera versión en castellano del Mini-Mental Status Examination) en la población general geriátrica. Medicina Clínica, 112, 767-774.
  • López-Pousa, S (2003). CAMDEX-R: prueba de exploración Cambridge revisada para la valoración de los trastornos mentales en la vejez. Adaptación española. Madrid: TEA Ediciones. Lozano-Gallego, M., Vilalta-Franch, J., Llinàs-Reglà, J., & López-Pousa, S. (1999). El Cambridge Cognitive Examination como instrumento de detección de demencia. Revista de Neurología, 28, 348-352.
  • Lozano-Gallego, M, Hernández, M., Turro, O., Pericot, I., López-Pousa, S., & Vilalta-Franch, J. (2009). Validación del Montreal Cognitive Assessment (MoCA): test de cribado para el deterioro cognitivo leve. Datos preliminares. Alzheimer, 43, 4-11.
  • Martínez delaIglesia, J., Onís Vilches, M.C., Dueñas Herrero, R., Albert Colomer, C., Aguado Taberné, C., & Luque Luque, R. (2002). Versión española del cuestionario de Yesavage abreviado (GDS) para el despistaje de depresión en mayores de 65 años: adaptación y validación. Revista de Medicina Familiar y Comunitaria, 12, 620-630.
  • National Institute of Statistics (2011). Indicadores sociales de España 2011 [Social indicators of Spain 2011]. Madrid: INE [cited 2014 Jun 22]. Available from: http://www.ine.es/daco/daco42/sociales11/sociales.htm.
  • Nasreddine, Z.S., Phillips, N.A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., et al. (2005). The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53, 695-699.
  • Nunes, P.V., Diniz, B.S., Radanovic, M., Abreu, I.D., Borelli, D.T., Yassuda, M.S., & Forlenza, O.V. (2008). CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education. International Journal of Geriatric Psychiatry, 23, 1127-1133.
  • Oulhaj, A., Wilcock, G.K., Smith, A.D., & de Jager, C.A. (2009). Predicting the time of conversion to MCI in the elderly: Role of verbal expression and learning. Neurology, 73, 1436-1442.
  • Olazarán, J., Mouronte, P., & Bermejo, F. (2005). Validez clínica de dos escalas de actividades instrumentales en la enfermedad de Alzheimer. Neurología, 20, 395-401.
  • Pfeiffer, J.W., Heslin, R., & Jones, J.E. (1976). Instrumentation in Human Relations Training. La Jolla, Ca.: University Associates.
  • Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C.P. (2013). The global prevalence of dementia: A systematic review and metaanalysis. Alzheimer’s & Dementia, 9, 63-75.
  • Roth, M., Tym, E., Mountjoy, C.Q., Huppert, F.A., Hendrie, H., Verma, S., et al. (1986). CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. The British Journal of Psychiatry, 149, 698-709.
  • Roth, M., Huppert, F.A., Mountjoy, C.Q., & Tym, E. (1998). CAMDEX-R: The Cambridge Examination for Mental Disorders of the Elderly-Revised. Cambridge: Cambridge University Press.
  • Schmand, B., Walstra, G., Lindeboom, J., Teunisse, S., & Jonker, C. (2000). Early detection of Alzheimer’s disease using the Cambridge cognitive examination (CAMCOG). Psychological Medicine, 30, 619-627.
  • Sheikh, J.I., & Yesavage, J.A. (1986). Geriatric Depression Scale (GDS). Recent evidence and development of a shorter version. In T.L. Brink (ed.), Clinical Gerontology: A guide to assessment and intervention (pp. 165-173). NY: The Haworth Press, Inc.
  • Spencer, R.J., Wendell, C.R., Giggey, P.P., Katzel, L.I., Lefkowitz, D.M., Siegel, E.L., et al. (2013). Psychometric limitations of the mini-mental state examination among nondemented older adults: An evaluation of neurocognitive and magnetic resonance imaging correlates. Experimental Aging Research, 39, 382-397.
  • Streiner, D.L. (2003). Staring at the beginning: An introduction to coefficient alpha and internal consistency. Journal of Personality Assessment, 80, 99-103.
  • Verhey, F.R., Huppert, F.A., Korten, E.C., Houx, P., de Vugt, M., van Lang, N., et al. (2003). Cross-national comparisons of the Cambridge Cognitive Examination-revised: The CAMCOG-R: Results from the European Harmonization Project for Instruments in Dementia. Age and Ageing, 32, 534-540.
  • Vilalta, J., Llinàs, J., López-Pousa, S., Amiel, J., & Vidal, C. (1990). CAMDEX. Validación de la adaptación española [CAMDEX. Validation of the Spanish adaptation]. Neurología, 5, 117-120.
  • Williams, J.G., Huppert, F.A., Matthews, F.E., & Nickson, J. (2003). Performance and normative values of a concise neuropsychological test (CAMCOG) in an elderly population sample. International Journal of Geriatric Psychiatry, 18, 631-644.
Data source: Dialnet